Login / Signup

Durability of the Efficacy and Safety of Dolutegravir-Based and Low-Dose Efavirenz-Based Regimens for the Initial Treatment of Human Immunodeficiency Virus Type 1 Infection in Cameroon: Week 192 Data of the NAMSAL-ANRS-12313 Study.

Mireille Mpoudi-EtameTamara Tovar SanchezMarwân-Al-Qays BousmahPierrette Omgba BassegaJustin OlingaEric MimbeMichel FoalemCamille ChiepSerge EdimoMarie VarloteauxRaphaël PelloquinNadine LamareSylvie BoyerMartine PeetersJacques ReynesAlexandra CalmyAndrew HillEric DelaporteCharles Kouanfacknull null
Published in: Open forum infectious diseases (2023)
 NCT02777229.
Keyphrases
  • human immunodeficiency virus
  • antiretroviral therapy
  • hiv infected
  • low dose
  • hiv infected patients
  • hepatitis c virus
  • hiv positive
  • hiv aids
  • high dose
  • combination therapy
  • deep learning